GoI increases interval between Covishield doses to 12-16 weeks; says decision ‘science-based’
New Delhi: The Centre Thursday approved extending the gap between the two doses of the Covishield vaccine to 12-16 weeks ...
Read moreDetails
New Delhi: The Centre Thursday approved extending the gap between the two doses of the Covishield vaccine to 12-16 weeks ...
Read moreDetailsChennai: A 40-year-old man who took part in the 'Covishield' vaccine trial here has alleged serious side effects, including a ...
Read moreDetailsNew Delhi: The Drugs Controller General of India (DCGI) has given nod to Serum Institute of India (SII) for conducting ...
Read moreDetailsNew Delhi: Serum Institute of India (SII) has partnered with ‘AstraZeneca’ for manufacturing the Oxford vaccine candidate for COVID-19. Serum ...
Read moreDetails
For an economy plagued by multiple ailments – a daily depreciating currency, growing household debt, high unemployment and inequality, exodus...
Read moreDetails
By Aakar Patel As a democratic society, it is expected that India’s authorities follow the rule of law. This includes...
Read moreDetails
By Dilip Cherian Three hours is barely enough time for a working lunch in New Delhi. Yet when UAE President...
Read moreDetails
Invariably US President Donald Trump says one thing and means something completely different has, by now, become clear to the...
Read moreDetails
